The impact of new digital customer engagement on front-line pharma
Ian Robinson and Mark Jones explore how this new digital era will impact engagement for front-line employees in pharma and why now might be...
Choosing the right digital health solutions for your company
Not all that glitters is gold so Paul Riley and Mark Davies share the three simple rules to help you choose the right digital...
Access Matters: The rise of the payer and implications for pharma
In a two-part series exclusive to Pharmafield, Neil Grubert and Mel Walker, Managing Director at Biopharma Futures, explore key trends in international market access....
Virtual and augmented reality in life sciences
Just as engineers in complex physical environments might use enhanced visualisation to gain a clearer understanding of a technical problem, or shoppers might use...
Demystifying the NHS White Paper – a representative’s position
With the release of the NHS White Paper, Star OUTiCO caught up with their Market Access Multi-Channel Account Manager, Steve Meadows, to get his...
New NHS operational planning guidance – what does it mean for pharma?
Why is the new NHS operational planning guidance so significant and what does it mean for pharmaceutical companies? Oli Hudson, Content Director at Wilmington...
Pf Awards 2021 – responding to the pandemic
The introduction of a new Pf Awards category for 2021 - Responsive Company Strategy - gave insight into companies who specifically demonstrated a rapid,...
What does it really take to conduct a vaccine trial at scale?
The Pfizer/BioNTech COVID-19 vaccine trial was one of the largest and fastest clinical trials ever conducted. ICON, a global provider of outsourced drug and...
COVID-19 and the impact on heart failure care
As the coronavirus pandemic continues to strain healthcare services in the UK, findings from the first patient survey into the impact of COVID-19 on...
Talking heads – what can pharma learn from 2020?
As we enter a new year and a next normal, taking time to reflect on the challenges and opportunities that 2020 presented to pharma...
Latest articles
Career close-up: Alessandra Dorigo
Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...
JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
OPEN Health acquires medical communications agency Spirit
OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...
Popular articles
MHRA approves first immunotherapy treatment for mesothelioma
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the combination of nivolumab plus ipilimumab for the first-line treatment of adult patients with...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic
Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Syneos Health and Aetion partner to offer real-world evidence solutions
Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership...
OPEN Health acquires medical communications agency Spirit
OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...